Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperuricemia | 16 | 2024 | 222 | 3.170 |
Why?
|
Gout | 19 | 2024 | 622 | 3.020 |
Why?
|
Symporters | 31 | 2013 | 362 | 2.920 |
Why?
|
Uric Acid | 17 | 2024 | 809 | 2.830 |
Why?
|
Kidney Tubules, Proximal | 6 | 2024 | 386 | 1.330 |
Why?
|
Chlorides | 15 | 2014 | 666 | 1.260 |
Why?
|
Organic Anion Transporters | 6 | 2024 | 101 | 1.160 |
Why?
|
Hyponatremia | 6 | 2020 | 278 | 1.150 |
Why?
|
Xenopus laevis | 16 | 2024 | 965 | 1.100 |
Why?
|
Multidrug Resistance-Associated Proteins | 2 | 2024 | 105 | 1.040 |
Why?
|
Sodium-Potassium-Chloride Symporters | 13 | 2012 | 106 | 1.020 |
Why?
|
Gout Suppressants | 6 | 2024 | 176 | 0.780 |
Why?
|
Loop of Henle | 4 | 2014 | 38 | 0.740 |
Why?
|
Antiporters | 6 | 2009 | 275 | 0.680 |
Why?
|
Adenosine | 2 | 2024 | 813 | 0.680 |
Why?
|
Caffeine | 1 | 2024 | 702 | 0.670 |
Why?
|
Hyperinsulinism | 1 | 2023 | 402 | 0.670 |
Why?
|
Receptors, Drug | 2 | 2010 | 156 | 0.660 |
Why?
|
Renal Insufficiency, Chronic | 6 | 2024 | 2306 | 0.660 |
Why?
|
Ion Transport | 6 | 2014 | 322 | 0.630 |
Why?
|
Kidney | 18 | 2022 | 7071 | 0.610 |
Why?
|
Sodium | 6 | 2022 | 1593 | 0.610 |
Why?
|
Potassium | 8 | 2014 | 1314 | 0.590 |
Why?
|
Glucose Transport Proteins, Facilitative | 4 | 2024 | 58 | 0.550 |
Why?
|
Oocytes | 16 | 2024 | 1168 | 0.530 |
Why?
|
Homeostasis | 6 | 2023 | 3341 | 0.520 |
Why?
|
Bicarbonates | 4 | 2022 | 293 | 0.520 |
Why?
|
Hypernatremia | 1 | 2016 | 78 | 0.500 |
Why?
|
Carrier Proteins | 13 | 2006 | 4924 | 0.470 |
Why?
|
Anion Transport Proteins | 5 | 2009 | 141 | 0.450 |
Why?
|
Glycosuria, Renal | 1 | 2013 | 4 | 0.440 |
Why?
|
Polyuria | 1 | 2013 | 37 | 0.430 |
Why?
|
Diuretics | 1 | 2016 | 611 | 0.410 |
Why?
|
Insulin | 4 | 2024 | 6608 | 0.400 |
Why?
|
Organic Cation Transport Proteins | 4 | 2024 | 61 | 0.380 |
Why?
|
Kidney Calculi | 5 | 2022 | 458 | 0.380 |
Why?
|
Biological Transport | 8 | 2024 | 2083 | 0.370 |
Why?
|
Molecular Biology | 1 | 2014 | 573 | 0.360 |
Why?
|
Kidney Tubules, Distal | 1 | 2010 | 43 | 0.350 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2009 | 59 | 0.320 |
Why?
|
Ascites | 2 | 2020 | 336 | 0.300 |
Why?
|
Arabidopsis | 3 | 2002 | 466 | 0.280 |
Why?
|
Cell Membrane | 6 | 2013 | 3640 | 0.280 |
Why?
|
Organic Anion Transporters, Sodium-Independent | 2 | 2024 | 28 | 0.270 |
Why?
|
ATP-Binding Cassette Transporters | 3 | 2024 | 566 | 0.270 |
Why?
|
Kidney Tubules | 2 | 2007 | 453 | 0.260 |
Why?
|
Animals | 63 | 2024 | 168887 | 0.260 |
Why?
|
Endocytosis | 1 | 2010 | 952 | 0.250 |
Why?
|
Sequence Homology | 1 | 2006 | 197 | 0.250 |
Why?
|
Cations | 4 | 2004 | 239 | 0.250 |
Why?
|
Kidney Diseases | 3 | 2013 | 2101 | 0.230 |
Why?
|
Allopurinol | 3 | 2020 | 203 | 0.220 |
Why?
|
Chloride-Bicarbonate Antiporters | 3 | 2009 | 103 | 0.220 |
Why?
|
Molecular Sequence Data | 17 | 2010 | 17605 | 0.210 |
Why?
|
Humans | 83 | 2024 | 766432 | 0.210 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2022 | 2477 | 0.210 |
Why?
|
Membrane Transport Proteins | 2 | 2007 | 1029 | 0.200 |
Why?
|
Monocarboxylic Acid Transporters | 2 | 2016 | 81 | 0.200 |
Why?
|
Protein Processing, Post-Translational | 1 | 2010 | 1963 | 0.200 |
Why?
|
Amino Acid Sequence | 15 | 2010 | 13410 | 0.200 |
Why?
|
Fanconi Syndrome | 1 | 2022 | 35 | 0.190 |
Why?
|
Carbon-Oxygen Lyases | 1 | 2001 | 8 | 0.190 |
Why?
|
Oxo-Acid-Lyases | 1 | 2020 | 23 | 0.180 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2021 | 16042 | 0.180 |
Why?
|
Maltose | 1 | 2021 | 39 | 0.180 |
Why?
|
Hyperoxaluria | 1 | 2020 | 33 | 0.180 |
Why?
|
DNA, Complementary | 5 | 2016 | 1988 | 0.180 |
Why?
|
Chromosomes, Human, Pair 15 | 2 | 2002 | 361 | 0.180 |
Why?
|
Uricosuric Agents | 1 | 2020 | 30 | 0.180 |
Why?
|
Biological Transport, Active | 4 | 2013 | 323 | 0.180 |
Why?
|
Calcium Oxalate | 1 | 2020 | 75 | 0.170 |
Why?
|
Epilepsy, Rolandic | 1 | 2001 | 57 | 0.170 |
Why?
|
Water-Electrolyte Balance | 2 | 2016 | 326 | 0.170 |
Why?
|
Genome-Wide Association Study | 6 | 2023 | 12807 | 0.170 |
Why?
|
Hypophosphatemia | 1 | 2021 | 92 | 0.170 |
Why?
|
Endodeoxyribonucleases | 1 | 2001 | 165 | 0.170 |
Why?
|
Nervous System Diseases | 2 | 2008 | 1659 | 0.170 |
Why?
|
Calcium | 5 | 2014 | 5781 | 0.160 |
Why?
|
Arabidopsis Proteins | 1 | 2001 | 261 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 6 | 2020 | 18075 | 0.160 |
Why?
|
Pregnancy Complications | 1 | 2013 | 2971 | 0.160 |
Why?
|
Cloning, Molecular | 5 | 2009 | 4167 | 0.160 |
Why?
|
Ferric Compounds | 1 | 2021 | 376 | 0.160 |
Why?
|
Anions | 4 | 2011 | 136 | 0.160 |
Why?
|
Protein Transport | 4 | 2010 | 1940 | 0.160 |
Why?
|
Acute Kidney Injury | 3 | 2022 | 1943 | 0.160 |
Why?
|
Epilepsy, Generalized | 1 | 2001 | 181 | 0.160 |
Why?
|
Mammals | 1 | 2004 | 1134 | 0.150 |
Why?
|
Catheters, Indwelling | 1 | 2020 | 436 | 0.150 |
Why?
|
DNA Mutational Analysis | 3 | 2008 | 4114 | 0.150 |
Why?
|
Neoplasm Proteins | 3 | 2024 | 3601 | 0.150 |
Why?
|
Phosphates | 1 | 2021 | 763 | 0.140 |
Why?
|
Models, Biological | 5 | 2009 | 9458 | 0.140 |
Why?
|
Membrane Glycoproteins | 1 | 2007 | 3702 | 0.130 |
Why?
|
Cation Exchange Resins | 1 | 2016 | 19 | 0.130 |
Why?
|
Patch-Clamp Techniques | 6 | 2012 | 924 | 0.130 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2023 | 1935 | 0.130 |
Why?
|
Genetic Markers | 2 | 2020 | 2603 | 0.130 |
Why?
|
Polystyrenes | 1 | 2016 | 102 | 0.130 |
Why?
|
Arginine Vasopressin | 1 | 2016 | 125 | 0.130 |
Why?
|
Erythrocytes | 4 | 2011 | 2412 | 0.130 |
Why?
|
Patient Care Management | 1 | 2019 | 301 | 0.130 |
Why?
|
Neurons | 6 | 2009 | 9515 | 0.130 |
Why?
|
Xenopus | 5 | 2012 | 709 | 0.120 |
Why?
|
Kidney Function Tests | 2 | 2019 | 684 | 0.120 |
Why?
|
Sequence Homology, Amino Acid | 6 | 2010 | 2746 | 0.120 |
Why?
|
Sulfates | 3 | 2010 | 380 | 0.120 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2002 | 1836 | 0.120 |
Why?
|
Education | 1 | 2018 | 531 | 0.120 |
Why?
|
Uromodulin | 1 | 2014 | 49 | 0.120 |
Why?
|
Drainage | 1 | 2020 | 1181 | 0.120 |
Why?
|
gamma-Aminobutyric Acid | 3 | 2012 | 1139 | 0.120 |
Why?
|
Bone Density Conservation Agents | 1 | 2022 | 791 | 0.120 |
Why?
|
Base Sequence | 7 | 2012 | 12412 | 0.120 |
Why?
|
Mice | 23 | 2013 | 81863 | 0.110 |
Why?
|
Tissue Distribution | 6 | 2009 | 2275 | 0.110 |
Why?
|
Cell Line | 3 | 2024 | 15563 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2023 | 2455 | 0.110 |
Why?
|
Protein Structure, Tertiary | 5 | 2009 | 3757 | 0.110 |
Why?
|
Rheumatology | 1 | 2020 | 619 | 0.110 |
Why?
|
Hyperkalemia | 1 | 2016 | 233 | 0.110 |
Why?
|
RNA, Messenger | 12 | 2016 | 12788 | 0.110 |
Why?
|
Immediate-Early Proteins | 1 | 2016 | 444 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 2880 | 0.110 |
Why?
|
Spinal Cord | 4 | 2008 | 1811 | 0.110 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2013 | 89 | 0.100 |
Why?
|
Kinetics | 7 | 2007 | 6285 | 0.100 |
Why?
|
RNA, Transfer | 1 | 2014 | 284 | 0.100 |
Why?
|
Brain | 6 | 2009 | 27156 | 0.100 |
Why?
|
DNA Repair | 1 | 2001 | 2048 | 0.100 |
Why?
|
Quantitative Trait Loci | 1 | 2020 | 2135 | 0.100 |
Why?
|
Homozygote | 3 | 2013 | 1774 | 0.090 |
Why?
|
Frameshift Mutation | 1 | 2013 | 392 | 0.090 |
Why?
|
Magnesium | 1 | 2014 | 815 | 0.090 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2012 | 320 | 0.090 |
Why?
|
Vasopressins | 2 | 2009 | 358 | 0.090 |
Why?
|
Medical Order Entry Systems | 1 | 2016 | 523 | 0.090 |
Why?
|
Furosemide | 3 | 2010 | 174 | 0.090 |
Why?
|
Hypertension | 4 | 2018 | 8614 | 0.090 |
Why?
|
Female | 35 | 2023 | 396354 | 0.090 |
Why?
|
Pregnancy Trimester, Second | 1 | 2013 | 737 | 0.090 |
Why?
|
Macrophage Activation | 1 | 2013 | 553 | 0.090 |
Why?
|
Enzyme Activators | 1 | 2010 | 56 | 0.090 |
Why?
|
Retinoid X Receptor alpha | 1 | 2010 | 22 | 0.090 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2010 | 92 | 0.090 |
Why?
|
Bartter Syndrome | 2 | 2002 | 23 | 0.090 |
Why?
|
Citric Acid | 2 | 2010 | 124 | 0.090 |
Why?
|
Synaptic Transmission | 3 | 2012 | 1175 | 0.090 |
Why?
|
Receptors, Nicotinic | 1 | 2013 | 494 | 0.090 |
Why?
|
Genetic Variation | 1 | 2005 | 6612 | 0.090 |
Why?
|
Drug Monitoring | 1 | 2016 | 960 | 0.080 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2010 | 85 | 0.080 |
Why?
|
Mushroom Bodies | 1 | 2009 | 25 | 0.080 |
Why?
|
Sequence Analysis, DNA | 4 | 2017 | 4779 | 0.080 |
Why?
|
Glycosylation | 1 | 2013 | 1100 | 0.080 |
Why?
|
Molecular Motor Proteins | 1 | 2009 | 105 | 0.080 |
Why?
|
Osmosis | 1 | 2009 | 103 | 0.080 |
Why?
|
Rats | 12 | 2016 | 23718 | 0.080 |
Why?
|
Blotting, Northern | 2 | 2002 | 1549 | 0.080 |
Why?
|
Glucose Intolerance | 1 | 2013 | 578 | 0.080 |
Why?
|
Thirst | 1 | 2009 | 42 | 0.080 |
Why?
|
Deamino Arginine Vasopressin | 1 | 2009 | 87 | 0.080 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2010 | 825 | 0.080 |
Why?
|
Suprachiasmatic Nucleus | 1 | 2009 | 141 | 0.080 |
Why?
|
Colitis, Ulcerative | 1 | 2021 | 1918 | 0.080 |
Why?
|
Phenotype | 5 | 2020 | 16721 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 474 | 0.080 |
Why?
|
Amino Acids | 2 | 2022 | 1711 | 0.080 |
Why?
|
Insulin Resistance | 2 | 2021 | 3989 | 0.080 |
Why?
|
Parathyroid Hormone | 2 | 2012 | 1791 | 0.080 |
Why?
|
Saline Solution, Hypertonic | 1 | 2009 | 116 | 0.080 |
Why?
|
Male | 29 | 2023 | 363975 | 0.080 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2010 | 330 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 478 | 0.080 |
Why?
|
Insect Proteins | 1 | 2009 | 253 | 0.080 |
Why?
|
Potassium Channels | 2 | 2003 | 534 | 0.080 |
Why?
|
Enzyme Activation | 3 | 2010 | 3585 | 0.070 |
Why?
|
Genetic Complementation Test | 2 | 2001 | 556 | 0.070 |
Why?
|
Neoplasms | 4 | 2022 | 22343 | 0.070 |
Why?
|
Receptors, Calcitriol | 1 | 2010 | 361 | 0.070 |
Why?
|
Gene Expression Regulation | 7 | 2013 | 11919 | 0.070 |
Why?
|
Sodium Channels | 1 | 2009 | 339 | 0.070 |
Why?
|
Cation Transport Proteins | 2 | 2007 | 325 | 0.070 |
Why?
|
Benzazepines | 1 | 2009 | 307 | 0.070 |
Why?
|
Endoplasmic Reticulum | 1 | 2013 | 1132 | 0.070 |
Why?
|
Hypotonic Solutions | 2 | 2006 | 48 | 0.070 |
Why?
|
Demyelinating Diseases | 1 | 2009 | 354 | 0.070 |
Why?
|
Rats, Wistar | 3 | 2016 | 1889 | 0.070 |
Why?
|
Registries | 2 | 2022 | 8344 | 0.070 |
Why?
|
Blotting, Western | 3 | 2017 | 5021 | 0.070 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2010 | 572 | 0.070 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 452 | 0.070 |
Why?
|
Disease Management | 2 | 2020 | 2530 | 0.070 |
Why?
|
Mutation | 7 | 2020 | 30220 | 0.070 |
Why?
|
RNA, Complementary | 1 | 2005 | 46 | 0.060 |
Why?
|
Alternative Splicing | 2 | 2009 | 1103 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1245 | 0.060 |
Why?
|
Ataxia | 1 | 2008 | 307 | 0.060 |
Why?
|
Eels | 1 | 2005 | 6 | 0.060 |
Why?
|
Ubiquitination | 1 | 2010 | 1000 | 0.060 |
Why?
|
Biotinylation | 1 | 2005 | 184 | 0.060 |
Why?
|
Phylogeny | 3 | 2003 | 2839 | 0.060 |
Why?
|
Fresh Water | 1 | 2005 | 82 | 0.060 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15639 | 0.060 |
Why?
|
Nutrition Surveys | 1 | 2012 | 1735 | 0.060 |
Why?
|
Isoenzymes | 1 | 2009 | 1688 | 0.060 |
Why?
|
Receptors, Dopamine D1 | 1 | 2006 | 276 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 3 | 2010 | 3736 | 0.060 |
Why?
|
Acidosis | 2 | 2013 | 271 | 0.060 |
Why?
|
Adult | 15 | 2022 | 223253 | 0.060 |
Why?
|
Mice, Knockout | 5 | 2014 | 14466 | 0.060 |
Why?
|
Proline | 1 | 2005 | 454 | 0.060 |
Why?
|
Chromosome Mapping | 3 | 2004 | 4618 | 0.060 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2006 | 415 | 0.060 |
Why?
|
Codon | 1 | 2005 | 599 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2001 | 9611 | 0.060 |
Why?
|
Electrophysiology | 2 | 2007 | 1263 | 0.060 |
Why?
|
Protein Isoforms | 3 | 2008 | 1715 | 0.050 |
Why?
|
Exons | 3 | 2008 | 2392 | 0.050 |
Why?
|
DNA Primers | 2 | 2005 | 2824 | 0.050 |
Why?
|
Xenopus Proteins | 1 | 2006 | 433 | 0.050 |
Why?
|
Multigene Family | 2 | 2003 | 1081 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2014 | 3141 | 0.050 |
Why?
|
Renal Dialysis | 2 | 2024 | 1790 | 0.050 |
Why?
|
Gene Deletion | 2 | 2008 | 2668 | 0.050 |
Why?
|
Drosophila melanogaster | 2 | 2009 | 1725 | 0.050 |
Why?
|
Sodium Chloride Symporters | 1 | 2002 | 10 | 0.050 |
Why?
|
Isomerism | 2 | 1999 | 197 | 0.050 |
Why?
|
Claudins | 2 | 2013 | 118 | 0.050 |
Why?
|
Glycine | 1 | 2005 | 671 | 0.050 |
Why?
|
Rubidium Radioisotopes | 1 | 2002 | 101 | 0.050 |
Why?
|
Isotonic Solutions | 1 | 2002 | 119 | 0.050 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2003 | 144 | 0.050 |
Why?
|
Mice, Inbred Strains | 2 | 2008 | 1767 | 0.050 |
Why?
|
Inosine | 1 | 2022 | 129 | 0.050 |
Why?
|
Deoxyribonuclease IV (Phage T4-Induced) | 1 | 2001 | 8 | 0.050 |
Why?
|
Middle Aged | 16 | 2021 | 223127 | 0.050 |
Why?
|
Umbilical Veins | 1 | 2002 | 423 | 0.050 |
Why?
|
Signal Transduction | 3 | 2014 | 23611 | 0.050 |
Why?
|
Acetyltransferases | 1 | 2002 | 230 | 0.050 |
Why?
|
DNA, Plant | 1 | 2001 | 51 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2019 | 4879 | 0.050 |
Why?
|
Stomach | 1 | 2006 | 700 | 0.050 |
Why?
|
Case-Control Studies | 5 | 2020 | 22245 | 0.050 |
Why?
|
Neoplasm Invasiveness | 1 | 2009 | 3608 | 0.050 |
Why?
|
Sex Factors | 2 | 2018 | 10614 | 0.050 |
Why?
|
Up-Regulation | 1 | 2010 | 4141 | 0.050 |
Why?
|
Cytoplasm | 1 | 2005 | 1505 | 0.050 |
Why?
|
DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2001 | 71 | 0.050 |
Why?
|
Fungal Proteins | 2 | 2002 | 900 | 0.040 |
Why?
|
Zebrafish Proteins | 1 | 2007 | 1017 | 0.040 |
Why?
|
Prognosis | 3 | 2020 | 29922 | 0.040 |
Why?
|
Glucose | 2 | 2022 | 4339 | 0.040 |
Why?
|
Aged | 13 | 2021 | 171234 | 0.040 |
Why?
|
Peripheral Nerves | 1 | 2004 | 490 | 0.040 |
Why?
|
Introns | 1 | 2002 | 965 | 0.040 |
Why?
|
Chromosomes | 1 | 2002 | 578 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2009 | 3689 | 0.040 |
Why?
|
Adenoma | 1 | 2010 | 2155 | 0.040 |
Why?
|
Mice, Inbred C57BL | 6 | 2014 | 22337 | 0.040 |
Why?
|
Alleles | 1 | 2010 | 6894 | 0.040 |
Why?
|
Colchicine | 1 | 2020 | 256 | 0.040 |
Why?
|
Kidney Cortex | 1 | 1998 | 167 | 0.040 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 1999 | 165 | 0.040 |
Why?
|
Colonic Neoplasms | 2 | 2010 | 2533 | 0.040 |
Why?
|
Kidney Medulla | 1 | 1998 | 169 | 0.040 |
Why?
|
Endonucleases | 1 | 2001 | 371 | 0.040 |
Why?
|
Macrophages | 1 | 2013 | 5782 | 0.040 |
Why?
|
Histone Deacetylases | 1 | 2002 | 712 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 12979 | 0.040 |
Why?
|
Cytoskeletal Proteins | 1 | 2003 | 1324 | 0.040 |
Why?
|
Neuropeptides | 1 | 2003 | 950 | 0.040 |
Why?
|
Choroid Plexus | 1 | 2001 | 249 | 0.040 |
Why?
|
Organic Anion Transport Protein 1 | 1 | 2017 | 6 | 0.040 |
Why?
|
Immunohistochemistry | 6 | 2012 | 11059 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12236 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 5 | 2012 | 8107 | 0.040 |
Why?
|
Gene Expression | 3 | 2009 | 7583 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3530 | 0.040 |
Why?
|
Electrochemistry | 1 | 1997 | 143 | 0.040 |
Why?
|
Chloride Channels | 1 | 1998 | 221 | 0.040 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2009 | 2039 | 0.040 |
Why?
|
Nerve Fibers | 1 | 2001 | 706 | 0.030 |
Why?
|
Creatinine | 1 | 2022 | 1916 | 0.030 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2002 | 713 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2005 | 2230 | 0.030 |
Why?
|
Seizures | 1 | 2009 | 2996 | 0.030 |
Why?
|
New Zealand | 1 | 2017 | 360 | 0.030 |
Why?
|
Central Nervous System | 1 | 2004 | 1345 | 0.030 |
Why?
|
Androgens | 1 | 2003 | 1279 | 0.030 |
Why?
|
Mendelian Randomization Analysis | 1 | 2021 | 1044 | 0.030 |
Why?
|
China | 1 | 2022 | 2383 | 0.030 |
Why?
|
Cell Size | 2 | 2012 | 626 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 1999 | 560 | 0.030 |
Why?
|
Transcription Factors | 3 | 2012 | 12147 | 0.030 |
Why?
|
Zebrafish | 3 | 2016 | 3035 | 0.030 |
Why?
|
Dexamethasone | 1 | 2003 | 1962 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2020 | 1365 | 0.030 |
Why?
|
Polymorphism, Genetic | 2 | 2002 | 4249 | 0.030 |
Why?
|
Hippocampus | 2 | 2012 | 3776 | 0.030 |
Why?
|
Plant Roots | 1 | 1995 | 121 | 0.030 |
Why?
|
Sequence Alignment | 1 | 1999 | 2176 | 0.030 |
Why?
|
Seeds | 1 | 1995 | 125 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2006 | 3048 | 0.030 |
Why?
|
Massachusetts | 2 | 2019 | 8885 | 0.030 |
Why?
|
Pregnancy | 2 | 2013 | 30235 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7426 | 0.030 |
Why?
|
Ammonium Chloride | 1 | 2013 | 72 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 2 | 2002 | 2678 | 0.030 |
Why?
|
Streptozocin | 1 | 2013 | 189 | 0.030 |
Why?
|
Potassium, Dietary | 1 | 2013 | 103 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2003 | 2158 | 0.030 |
Why?
|
Ovarian Neoplasms | 2 | 2009 | 4904 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2022 | 12423 | 0.030 |
Why?
|
Cell Line, Tumor | 4 | 2013 | 17082 | 0.030 |
Why?
|
Tunicamycin | 1 | 2013 | 108 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2014 | 540 | 0.030 |
Why?
|
Radiation Tolerance | 1 | 1995 | 475 | 0.030 |
Why?
|
Rabbits | 1 | 1999 | 4752 | 0.030 |
Why?
|
Cohort Studies | 4 | 2020 | 41703 | 0.030 |
Why?
|
Niacin | 1 | 2013 | 116 | 0.030 |
Why?
|
DNA | 3 | 2012 | 7207 | 0.030 |
Why?
|
Quality Improvement | 2 | 2019 | 3849 | 0.020 |
Why?
|
Genetic Loci | 1 | 2021 | 2630 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2012 | 368 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2002 | 2977 | 0.020 |
Why?
|
Diet, Sodium-Restricted | 1 | 2013 | 291 | 0.020 |
Why?
|
Lipids | 1 | 2022 | 3319 | 0.020 |
Why?
|
Sodium Chloride, Dietary | 1 | 2013 | 300 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2019 | 1404 | 0.020 |
Why?
|
Cross Infection | 1 | 2000 | 1427 | 0.020 |
Why?
|
Oxalic Acid | 1 | 2010 | 20 | 0.020 |
Why?
|
Protein Stability | 1 | 2013 | 577 | 0.020 |
Why?
|
Pulmonary Edema | 1 | 1994 | 409 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2019 | 949 | 0.020 |
Why?
|
Genome | 1 | 1999 | 1751 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26294 | 0.020 |
Why?
|
Reticulocytes | 1 | 2011 | 287 | 0.020 |
Why?
|
Chemotaxis | 1 | 2013 | 598 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2270 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2013 | 642 | 0.020 |
Why?
|
Gastrin-Releasing Peptide | 1 | 2009 | 36 | 0.020 |
Why?
|
Drug Utilization | 1 | 2016 | 1187 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 1995 | 1101 | 0.020 |
Why?
|
Acetaminophen | 1 | 1994 | 549 | 0.020 |
Why?
|
Crystallization | 2 | 2005 | 518 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 2002 | 5794 | 0.020 |
Why?
|
Surface Properties | 1 | 2013 | 1153 | 0.020 |
Why?
|
Genetic Linkage | 1 | 1995 | 2342 | 0.020 |
Why?
|
Japan | 1 | 2014 | 1417 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2013 | 1677 | 0.020 |
Why?
|
Bumetanide | 2 | 2000 | 101 | 0.020 |
Why?
|
Microdissection | 1 | 2009 | 150 | 0.020 |
Why?
|
Hospitalization | 1 | 2009 | 10812 | 0.020 |
Why?
|
Pancreas | 1 | 2016 | 1699 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2010 | 463 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4566 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2022 | 3428 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 2003 | 7607 | 0.020 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 2009 | 179 | 0.020 |
Why?
|
Sulfonamides | 1 | 1999 | 1978 | 0.020 |
Why?
|
Positive-Pressure Respiration | 1 | 1994 | 712 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2024 | 4278 | 0.020 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2010 | 156 | 0.020 |
Why?
|
Protein Folding | 1 | 2013 | 868 | 0.020 |
Why?
|
Proteins | 1 | 2003 | 6002 | 0.020 |
Why?
|
Interleukins | 1 | 2013 | 794 | 0.020 |
Why?
|
Rats, Inbred WKY | 1 | 2008 | 150 | 0.020 |
Why?
|
Rats, Inbred SHR | 1 | 2008 | 187 | 0.020 |
Why?
|
Electrophysiological Phenomena | 1 | 2009 | 309 | 0.020 |
Why?
|
Body Temperature Regulation | 1 | 1989 | 292 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9333 | 0.020 |
Why?
|
Triiodothyronine | 1 | 1989 | 493 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2018 | 10379 | 0.020 |
Why?
|
Oxalates | 1 | 2007 | 99 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3427 | 0.020 |
Why?
|
Comorbidity | 2 | 2018 | 10579 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2009 | 697 | 0.020 |
Why?
|
G-Protein-Coupled Receptor Kinase 4 | 1 | 2006 | 3 | 0.020 |
Why?
|
G-Protein-Coupled Receptor Kinases | 1 | 2006 | 5 | 0.020 |
Why?
|
Age Factors | 2 | 2018 | 18395 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3624 | 0.020 |
Why?
|
Logistic Models | 2 | 2017 | 13276 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15897 | 0.020 |
Why?
|
Epilepsy | 1 | 2002 | 3317 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2012 | 1967 | 0.020 |
Why?
|
Polysaccharides | 1 | 2013 | 1020 | 0.020 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2006 | 50 | 0.020 |
Why?
|
Heparin Antagonists | 1 | 2006 | 34 | 0.020 |
Why?
|
Biomedical Research | 1 | 2021 | 3458 | 0.020 |
Why?
|
Urate Oxidase | 1 | 2005 | 33 | 0.020 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2010 | 877 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2013 | 2215 | 0.020 |
Why?
|
Lasers | 1 | 2009 | 951 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2009 | 2470 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10092 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 1994 | 1241 | 0.020 |
Why?
|
Fruit | 1 | 2010 | 1166 | 0.010 |
Why?
|
Vegetables | 1 | 2010 | 1199 | 0.010 |
Why?
|
Dopamine Antagonists | 1 | 2006 | 279 | 0.010 |
Why?
|
Microscopy, Fluorescence | 2 | 2002 | 2629 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2013 | 1389 | 0.010 |
Why?
|
NF-kappa B | 1 | 2013 | 2495 | 0.010 |
Why?
|
United States | 3 | 2020 | 72910 | 0.010 |
Why?
|
Genes, Viral | 1 | 1985 | 654 | 0.010 |
Why?
|
Seawater | 1 | 2005 | 126 | 0.010 |
Why?
|
Prospective Studies | 3 | 2022 | 54826 | 0.010 |
Why?
|
DNA Damage | 1 | 2014 | 2464 | 0.010 |
Why?
|
Culture Media | 2 | 2003 | 893 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6061 | 0.010 |
Why?
|
Genomics | 1 | 2020 | 5924 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2013 | 4270 | 0.010 |
Why?
|
Adipose Tissue, Brown | 1 | 1989 | 776 | 0.010 |
Why?
|
Dopamine Agonists | 1 | 2006 | 346 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2013 | 2839 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2012 | 2430 | 0.010 |
Why?
|
Dihydrotestosterone | 1 | 2003 | 194 | 0.010 |
Why?
|
Transcription Factors, TFII | 1 | 2002 | 62 | 0.010 |
Why?
|
Anemia, Sickle Cell | 1 | 2011 | 1063 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2009 | 1791 | 0.010 |
Why?
|
Genome, Plant | 1 | 2002 | 84 | 0.010 |
Why?
|
Protein Kinases | 1 | 2009 | 1608 | 0.010 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 1985 | 481 | 0.010 |
Why?
|
CREB-Binding Protein | 1 | 2002 | 147 | 0.010 |
Why?
|
Protein Conformation | 1 | 2010 | 3946 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2009 | 65202 | 0.010 |
Why?
|
Neurosecretory Systems | 1 | 2003 | 223 | 0.010 |
Why?
|
Histone Deacetylase 1 | 1 | 2002 | 133 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21509 | 0.010 |
Why?
|
Purines | 1 | 2005 | 616 | 0.010 |
Why?
|
Blotting, Southern | 1 | 2002 | 774 | 0.010 |
Why?
|
Simplexvirus | 1 | 1985 | 805 | 0.010 |
Why?
|
Pentylenetetrazole | 1 | 2002 | 72 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 4348 | 0.010 |
Why?
|
Convulsants | 1 | 2002 | 70 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 2003 | 655 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2009 | 1865 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2011 | 2332 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 5789 | 0.010 |
Why?
|
Marine Toxins | 1 | 2000 | 24 | 0.010 |
Why?
|
Barium Compounds | 1 | 2000 | 19 | 0.010 |
Why?
|
Okadaic Acid | 1 | 2000 | 67 | 0.010 |
Why?
|
Ethylmaleimide | 1 | 2000 | 69 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2009 | 1446 | 0.010 |
Why?
|
Sharks | 1 | 2000 | 21 | 0.010 |
Why?
|
Rubidium | 1 | 2000 | 120 | 0.010 |
Why?
|
Protein Biosynthesis | 2 | 2003 | 2094 | 0.010 |
Why?
|
Adrenalectomy | 1 | 2003 | 347 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15820 | 0.010 |
Why?
|
Pyrethrins | 1 | 2000 | 47 | 0.010 |
Why?
|
Histone Acetyltransferases | 1 | 2002 | 332 | 0.010 |
Why?
|
Sodium Chloride | 1 | 2003 | 579 | 0.010 |
Why?
|
Schizosaccharomyces | 1 | 2002 | 236 | 0.010 |
Why?
|
Chimera | 1 | 2002 | 455 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3424 | 0.010 |
Why?
|
Time Factors | 3 | 2009 | 40116 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2011 | 11648 | 0.010 |
Why?
|
Protein Phosphatase 1 | 1 | 2000 | 135 | 0.010 |
Why?
|
Synapses | 1 | 2009 | 1759 | 0.010 |
Why?
|
Entorhinal Cortex | 1 | 2002 | 285 | 0.010 |
Why?
|
Genes, Recessive | 1 | 2002 | 625 | 0.010 |
Why?
|
Axons | 1 | 2008 | 1675 | 0.010 |
Why?
|
Life Style | 1 | 2011 | 3926 | 0.010 |
Why?
|
Protein Engineering | 1 | 2003 | 554 | 0.010 |
Why?
|
Sirtuins | 1 | 2002 | 323 | 0.010 |
Why?
|
Peripheral Nervous System | 1 | 2001 | 151 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3795 | 0.010 |
Why?
|
Biliverdine | 1 | 1999 | 28 | 0.010 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 1999 | 100 | 0.010 |
Why?
|
Immunoblotting | 1 | 2002 | 1646 | 0.010 |
Why?
|
Oxazoles | 1 | 2000 | 198 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2002 | 818 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2002 | 582 | 0.010 |
Why?
|
Purkinje Cells | 1 | 2001 | 228 | 0.010 |
Why?
|
Enterococcus | 1 | 2000 | 158 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6422 | 0.010 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2000 | 327 | 0.010 |
Why?
|
Sheep | 1 | 2001 | 1448 | 0.010 |
Why?
|
Heparin | 1 | 2006 | 1634 | 0.010 |
Why?
|
Enzyme Inhibitors | 2 | 1999 | 3721 | 0.010 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2000 | 264 | 0.010 |
Why?
|
Risk Factors | 3 | 2013 | 74828 | 0.010 |
Why?
|
Apoptosis | 1 | 2014 | 9507 | 0.010 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 1999 | 213 | 0.010 |
Why?
|
NADP | 1 | 1999 | 229 | 0.010 |
Why?
|
Neural Inhibition | 1 | 2002 | 589 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2002 | 1525 | 0.010 |
Why?
|
Mutagenesis | 1 | 2002 | 1228 | 0.010 |
Why?
|
Corpus Callosum | 1 | 2002 | 751 | 0.010 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2000 | 340 | 0.010 |
Why?
|
Candidiasis | 1 | 2000 | 372 | 0.010 |
Why?
|
Isoquinolines | 1 | 1999 | 350 | 0.010 |
Why?
|
Recurrence | 1 | 2010 | 8478 | 0.010 |
Why?
|
Pneumonia, Bacterial | 1 | 2000 | 319 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2003 | 1089 | 0.010 |
Why?
|
Protein Binding | 1 | 2009 | 9315 | 0.010 |
Why?
|
Canada | 1 | 2002 | 2123 | 0.010 |
Why?
|
Heme | 1 | 1999 | 316 | 0.010 |
Why?
|
Porphyrins | 1 | 1999 | 352 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2009 | 5129 | 0.010 |
Why?
|
Intestines | 1 | 2006 | 1904 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 3607 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 1999 | 484 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 24272 | 0.010 |
Why?
|
Haplotypes | 1 | 2002 | 2727 | 0.010 |
Why?
|
Organ Specificity | 1 | 2001 | 1966 | 0.010 |
Why?
|
Propofol | 1 | 2002 | 608 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2012 | 8925 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9521 | 0.010 |
Why?
|
Heterozygote | 1 | 2002 | 2795 | 0.010 |
Why?
|
Primary Health Care | 1 | 2011 | 4734 | 0.010 |
Why?
|
Cyclic AMP | 1 | 1999 | 1472 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1998 | 1887 | 0.010 |
Why?
|
Hardness Tests | 1 | 1994 | 9 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2000 | 2920 | 0.010 |
Why?
|
Lysine | 1 | 1999 | 994 | 0.010 |
Why?
|
Crystallography | 1 | 1994 | 110 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1999 | 1168 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18322 | 0.010 |
Why?
|
Urinary Tract Infections | 1 | 2000 | 804 | 0.010 |
Why?
|
Diarrhea | 1 | 2000 | 1317 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 2002 | 1475 | 0.010 |
Why?
|
Drosophila Proteins | 1 | 2002 | 1704 | 0.010 |
Why?
|
Bacteremia | 1 | 2000 | 987 | 0.010 |
Why?
|
Trans-Activators | 1 | 2002 | 2854 | 0.010 |
Why?
|
Patient Admission | 1 | 2000 | 1364 | 0.010 |
Why?
|
Antibodies | 1 | 2001 | 2421 | 0.010 |
Why?
|
Models, Genetic | 1 | 2002 | 3450 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2013 | 39283 | 0.010 |
Why?
|
Anticonvulsants | 1 | 2002 | 1920 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 81588 | 0.010 |
Why?
|
Masks | 1 | 1994 | 212 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 2000 | 1396 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2000 | 6507 | 0.010 |
Why?
|
Chromatin | 1 | 2002 | 2979 | 0.010 |
Why?
|
Anisotropy | 1 | 1994 | 1285 | 0.010 |
Why?
|
Oxygen Inhalation Therapy | 1 | 1994 | 418 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2006 | 18979 | 0.010 |
Why?
|
Population Surveillance | 1 | 2000 | 2594 | 0.010 |
Why?
|
Guanosine Diphosphate | 1 | 1989 | 79 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 1994 | 1138 | 0.010 |
Why?
|
RNA | 1 | 1999 | 2715 | 0.000 |
Why?
|
Odds Ratio | 1 | 2000 | 9654 | 0.000 |
Why?
|
Iodide Peroxidase | 1 | 1989 | 295 | 0.000 |
Why?
|
Diet | 1 | 2005 | 8085 | 0.000 |
Why?
|
Membrane Proteins | 1 | 2003 | 7866 | 0.000 |
Why?
|
Deoxyribonucleotides | 1 | 1985 | 43 | 0.000 |
Why?
|
Diphosphates | 1 | 1985 | 89 | 0.000 |
Why?
|
Inflammation | 1 | 2005 | 10860 | 0.000 |
Why?
|
Thyroxine | 1 | 1989 | 665 | 0.000 |
Why?
|
Cold Temperature | 1 | 1989 | 795 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2010 | 59538 | 0.000 |
Why?
|
Thyroidectomy | 1 | 1989 | 912 | 0.000 |
Why?
|
Obesity | 1 | 2005 | 13088 | 0.000 |
Why?
|
Acute Disease | 1 | 1994 | 7240 | 0.000 |
Why?
|
Cell Biology | 1 | 1963 | 91 | 0.000 |
Why?
|
Tissue Culture Techniques | 1 | 1963 | 287 | 0.000 |
Why?
|
Adaptation, Physiological | 1 | 1989 | 1312 | 0.000 |
Why?
|
Models, Theoretical | 1 | 1994 | 3562 | 0.000 |
Why?
|
Oxygen | 1 | 1994 | 4251 | 0.000 |
Why?
|
Gallbladder Neoplasms | 1 | 1963 | 190 | 0.000 |
Why?
|
Nose Neoplasms | 1 | 1963 | 250 | 0.000 |
Why?
|
Albumins | 1 | 1963 | 578 | 0.000 |
Why?
|
Liposarcoma | 1 | 1963 | 288 | 0.000 |
Why?
|
Neoplasms, Experimental | 1 | 1963 | 1227 | 0.000 |
Why?
|
Osteosarcoma | 1 | 1963 | 908 | 0.000 |
Why?
|
Mesothelioma | 1 | 1963 | 774 | 0.000 |
Why?
|
Binding Sites | 1 | 1985 | 6010 | 0.000 |
Why?
|
Mitochondria | 1 | 1989 | 3676 | 0.000 |
Why?
|
Sarcoma | 1 | 1963 | 1802 | 0.000 |
Why?
|
Heart Failure | 1 | 1994 | 11816 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 1963 | 6361 | 0.000 |
Why?
|
Adolescent | 1 | 1963 | 88898 | 0.000 |
Why?
|